
CorticosteroidIndian prescription status not found in lists checkedJan Aushadhi listedAppears in banned-combination list entries
Deflazacort
डेफ्लाज़ाकोर्ट
Deflazacort is a corticosteroid tablet used to treat Duchenne muscular dystrophy in patients aged 2 years and older. It can suppress the immune system, raise infection risk and affect hormones, bones, mood and eyes. It should be stopped gradually, not suddenly.
- Generic name
- Deflazacort
- Used for
- Treating Duchenne muscular dystrophy in patients 2 years of age and older.
- Label used
- Tablets label, oral, DailyMed set 34a03eb7, effective 2026-08
- Prescription status (India)
- Not found in the Schedule H/H1/X/G lists we checked
- On NLEM 2022
- Not found in the list we checked
- NPPA price ceiling
- Not listed in the lists we checked
More facts
- Jan Aushadhi
- Listed (3 product rows)
- Banned combinations
- 1 entries mention it; use the checker for your combination
Compiled from official drug labels and Indian government sources. Always follow your doctor's or pharmacist's advice.
Safety at a glance
- AlcoholNot mentioned in label text
- PregnancyCaution in label textSee wording
- BreastfeedingCaution in label textSee wording
- DrivingNot mentioned in label text
- KidneyCaution in label textSee wording
- LiverNot mentioned in label text
Taken only from the label text cited on this page. "Not mentioned" does not mean safe. Ask your doctor or pharmacist.
What is deflazacort used for?
The label describes deflazacort as a corticosteroid for Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
- Duchenne muscular dystrophy, age 2 years and older
It is used to treat Duchenne muscular dystrophy.
Source1
How does deflazacort work?
The label says its active form acts on the glucocorticoid receptor, giving anti-inflammatory and immune-suppressing effects.
The label says the exact way it helps in Duchenne muscular dystrophy is unknown.
It calms inflammation and immune activity, though how it helps in DMD is not known.
Source1
How is deflazacort usually taken?
This page covers the US label for deflazacort tablets taken by mouth, with the dosing the label gives for adults and, where the label says so, children.
This is label-level information, not personal advice. Indian pack labels may differ, and your prescriber's instruction always comes first.
The label describes a once-daily dose of about 0.9 mg/kg. Tablets can be taken with or without food, and can be crushed and mixed with applesauce.
The label says not to take it with grapefruit juice. Vaccinations should be completed per guidelines before starting, and live vaccines at least 4 to 6 weeks before.
If used for more than a few days, the dose must be decreased gradually. The label says to give one third of the dose with moderate or strong CYP3A4 inhibitors.
- Once daily, with or without food
- No grapefruit juice
- Reduce gradually, never stop suddenly
- Vaccines before starting
It is taken once daily and must be reduced gradually when stopping.
Source1
What are the side effects of deflazacort?
Common
- The label lists common effects of 10% or more: Cushingoid appearance, weight gain, increased appetite, upper respiratory infection, cough, frequent urination, excess hair growth, central obesity and nasopharyngitis.
- Weight gain and increased appetite
- Cushingoid appearance
- Upper respiratory infection
- Mood or behaviour changes
- Cataract or eye problems
Serious: get help
- Serious effects described include infection, raised blood pressure, gut perforation, mood changes, bone loss, eye problems, serious skin rashes, and anaphylaxis.
Weight gain, appetite increase and infections are common; serious effects can affect many organs.
Source1
Who should be careful with deflazacort?
The label says it is contraindicated with known hypersensitivity to deflazacort or its inactive ingredients.
It warns of adrenal suppression, Cushing syndrome, high blood sugar, infection risk, bone loss, eye pressure, and mood disturbances. Live vaccines should not be given during immunosuppressive doses.
The label says corticosteroids cross the placenta and should be used in pregnancy only if benefit justifies risk.
- Hypersensitivity is a contraindication
- Infection risk, which may be masked
- Do not stop suddenly
- No live vaccines while on it
- Skin rash: discontinue at first sign unless clearly unrelated
It weakens defences against infection and affects hormones, so monitoring is needed.
Source1
What medicines interact with deflazacort?
- CYP3A4 inhibitors: one third dose
- CYP3A4 inducers: avoid
- Neuromuscular blocking drugs
- The label says moderate or strong CYP3A4 inhibitors, such as clarithromycin, fluconazole, diltiazem, verapamil and grapefruit juice, call for one third of the dose.
- Strong or moderate CYP3A4 inducers, such as rifampin, efavirenz, carbamazepine and phenytoin, should be avoided.
- Neuromuscular blockers may raise risk of acute myopathy.
No match in this label text. Ask your pharmacist about any medicine you take.
Some antibiotics, antifungals and seizure drugs change how it works.
Source1
How should deflazacort be stored?
The label gives a storage range of 15 to 30 degrees C.
Follow the storage line on your own pack, and keep medicines out of the reach of children.
Follow the storage instructions on your pack.
Source1
Is deflazacort a prescription medicine in India?
We did not find deflazacort in the Drugs Rules 1945 Schedule H, H1, X or G rows we checked, so we cannot state its Indian prescription status from our lists. Ask your pharmacist or doctor.
We did not find deflazacort on the National List of Essential Medicines 2022 in the list we checked.
The Jan Aushadhi (PMBJP) list we checked has 3 product rows that mention deflazacort. We did not capture prices for them.
The banned fixed-dose combination list we checked has 1 entries that mention deflazacort. This does not mean the single medicine is banned. Use our checker for a specific combination.
We did not find deflazacort in the Schedule H, H1, X or G rows we checked, not found on NLEM 2022.
Source2
What is the price ceiling for deflazacort?
Jan Aushadhi lists deflazacort products including Deflazacort Tablets 6 mg 6 mg; Deflazacort 30mg and Tamsulosin 0.4mg Tablets 30mg; Deflazacort oral Suspension 6mg per 5ml 6mg per 5ml. We have not shown a price for them. Check the pack and the seller for the actual price.
NPPA lists per-unit ceilings where a formulation is scheduled. Check the pack and seller.
Source2
Frequently asked questions
Can I drink alcohol while taking deflazacort?
The label we reviewed does not say. Ask your doctor or pharmacist.
Source1
Is deflazacort safe in pregnancy and breastfeeding?
The label says corticosteroids should be used in pregnancy only if benefit justifies risk to the fetus. Ask your doctor or pharmacist about breastfeeding.
Source1
Should deflazacort be taken with food?
The label says it can be taken with or without food, but not with grapefruit juice. Ask your doctor or pharmacist.
Source1
Can deflazacort affect driving or alertness?
The label we reviewed does not say. Ask your doctor or pharmacist.
Source1
Can children or older adults take deflazacort?
The label covers patients 2 years and older, dosed by weight. The label we reviewed does not address older adults. Ask your doctor or pharmacist.
Source1
Is deflazacort on the NLEM and Jan Aushadhi list?
We did not find it on NLEM 2022. Yes, several deflazacort products are in the Jan Aushadhi list we checked.
Source2
Sources
- 1U.S. FDA-approved label (DailyMed) (34a03eb7-74f5-4471-e063-6394a90aca63) Open source · 2026-10-15
- 2PMBJP (Jan Aushadhi) product list (p17:sno389) Open source · 2026-10-15
Compiled by software from the sources above and checked by automated rules. Last checked: 2026-10-15 · How we use sources · Report a correction
This information is educational and is not a substitute for advice from your doctor or pharmacist. It does not tell you what dose you personally should take. In an emergency call 112.